Scripta Therapeutics

About Scripta Therapeutics

Scripta Therapeutics is a drug discovery company focused on modulating transcription factor activity to address the underlying biological causes of diseases. Their mission is to develop transformative therapeutics that can halt or reverse disease progression, starting with neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS.

Products & Services

Drug Discovery Platform:A biology-first, AI/ML-driven platform for drug discovery that maps transcription factors, identifies molecules and targets to modulate them, and validates results in patient-derived models.

Therapeutics for Neurodegenerative Diseases:Focused on developing disease-modifying therapies for conditions such as Alzheimer's, Parkinson's, and ALS.

Specialties

Transcription Factor Modulation AI/ML in Drug Discovery Neurodegenerative Disease Therapies Genome-Wide Mapping Patient-Derived Models

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed T: - FT: Seed	A: 12000000 MR: - FA: $12 million FAN: 12000000	D: 2025-11-13 FD: 2025-11-13	6 investors

Seed Latest

2025-11-13

$12.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Peter Hamley

CEO and Founder

J

Jerry Huang

VP of Machine Learning

A

Andy Walker

VP of Bioinformatics

J

John Blackwood

VP of Biology

N

Noel Buckley

Academic co-founder

R

Raymond Barlow

Non-Executive Director

View 5 more team members with Pro

Unlock Full Team Directory

Recent News